Type I interferon response and vascular alteration in chilblain‐like lesions during the COVID‐19 outbreak*

• DOI: 10.1111/bjd.20707
• Publication Date: 2021-10-08T08:32:48Z
• Authors: L. Frumholtz; J.‐D. Bouaziz; M. Battistella; J. Hadjadj; R. Chocron; D. Bengoufa; H. Le Buanec; L. Barnabei; S. Meynier; O. Schwartz; L. Grzelak; N. Smith; B. Charbit; D. Duffy; N. Yatim; A. Calugareanu; A. Philippe; C.L. Guerin; B. Joly; V. Siguret; L. Jaume; H. Bachelez; M. Bagot; F. Rieux‐Laucat; S. Maylin; J. Legoff; C. Delaugerre; N. Gendron; D.M. Smadja; C. Cassius
• Keywords: 2019-20 coronavirus outbreak

BackgroundThe outbreak of chilblain‐like lesions (CLL) during the COVID‐19 pandemic has been reported extensively, potentially related to SARS‐CoV‐2 infection, yet its underlying pathophysiology is unclear.